CircSMAD2 Inhibits the Epithelial–Mesenchymal Transition by Targeting miR-629 in Hepatocellular Carcinoma [Retraction]
OncoTargets and Therapy · 2026-10 · Volume 19 · 1-2
DOI: 10.2147/ott.s665164 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-10. Verfasst von Xianwei W Zhang und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, X. W., Luo, P., Jing, W., Zhou, H., Liang, C. Z., & Tu, J. C. (2026). CircSMAD2 Inhibits the Epithelial–Mesenchymal Transition by Targeting miR-629 in Hepatocellular Carcinoma [Retraction]. OncoTargets and Therapy, Volume 19, 1-2. https://doi.org/10.2147/ott.s665164
Vancouver
Zhang XW, Luo P, Jing W, Zhou H, Liang CZ, Tu JC. CircSMAD2 Inhibits the Epithelial–Mesenchymal Transition by Targeting miR-629 in Hepatocellular Carcinoma [Retraction]. OncoTargets and Therapy. 2026;Volume 19:1-2. doi:10.2147/ott.s665164
BibTeX
@article{Zhang2026,
author = {Zhang, Xianwei W and Luo, Ping and Jing, Wei and Zhou, Hu and Liang, Chunzi Z and Tu, Jiancheng C},
title = {CircSMAD2 Inhibits the Epithelial–Mesenchymal Transition by Targeting miR-629 in Hepatocellular Carcinoma [Retraction]},
journal = {OncoTargets and Therapy},
year = {2026},
volume = {Volume 19},
pages = {1--2},
doi = {10.2147/ott.s665164}
}
EUVIMED